{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:37:29Z","timestamp":1776217049889,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Data on the characteristics and outcomes of patients hospitalized for Coronavirus Disease 2019 (COVID-19) in Thailand are limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine characteristics and outcomes and identify risk factors for hospital mortality for hospitalized patients with COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively reviewed the medical records of patients who had COVID-19 infection and were admitted to the cohort ward or ICUs at Siriraj Hospital between January 2020 and December 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 2,430 patients included in this study, 229 (9.4%) died; the mean age was 54 years, 40% were men, 81% had at least one comorbidity, and 13% required intensive care unit (ICU). Favipiravir (86%) was the main antiviral treatment. Corticosteroids and rescue anti-inflammatory therapy were used in 74 and 6%, respectively. Admission to the ICU was the only factor associated with reduced mortality [odds ratio (OR) 0.01, 95% confidence interval (CI) 0.01\u20130.05, <jats:italic>P<\/jats:italic> &amp;lt; 0.001], whereas older age (OR 14.3, 95%CI 5.76\u201335.54, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), high flow nasal cannula (HFNC; OR 9.2, 95% CI 3.9\u201321.6, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), mechanical ventilation (OR 269.39, 95%CI 3.6\u20132173.63, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), septic shock (OR 7.79, 95%CI, 2.01\u201330.18, <jats:italic>P<\/jats:italic> = 0.003), and hydrocortisone treatment (OR 27.01, 95%CI 5.29\u2013138.31, <jats:italic>P<\/jats:italic> &amp;lt; 0.001) were factors associated with in-hospital mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The overall mortality of hospitalized patients with COVID-19 was 9%. The only factor associated with reduced mortality was admission to the ICU. Therefore, appropriate selection of patients for admission to the ICU, strategies to limit disease progression and prevent intubation, and early detection and prompt treatment of nosocomial infection can improve survival in these patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1061955","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T17:00:40Z","timestamp":1672851640000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Characteristics, outcomes, and risk factors for in-hospital mortality of COVID-19 patients: A retrospective study in Thailand"],"prefix":"10.3389","volume":"9","author":[{"given":"Thummaporn","family":"Naorungroj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanuwong","family":"Viarasilpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surat","family":"Tongyoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aeckapholpholladet","family":"Detkaew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanchanok","family":"Pinpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawish","family":"Wimolwattanaphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranistha","family":"Ratanarat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panuwat","family":"Promsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preecha","family":"Thamrongpiroj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akekarin","family":"Phumpichet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chairat","family":"Permpikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","year":"2022","journal-title":"WHO Coronavirus (COVID-19) Dashboard."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06536-3","article-title":"Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.","volume":"21","author":"Dessie","year":"2021","journal-title":"BMC Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03098-9","article-title":"Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China.","volume":"24","author":"Xu","year":"2020","journal-title":"Crit Care."},{"key":"B9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S2213-2600(21)00229-0","article-title":"Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.","volume":"9","author":"Estenssoro","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.","volume":"180","author":"Grasselli","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1093\/cid\/ciaa1012","article-title":"Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET).","volume":"72","author":"Kim","year":"2021","journal-title":"Clin Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4269\/ajtmh.20-0442","article-title":"Critical Care Management of Patients with COVID-19: early Experience in Thailand.","volume":"103","author":"Ratanarat","year":"2020","journal-title":"Am J Trop Med Hyg."},{"key":"B14","article-title":"Mechanical ventilator support and prone positioning in COVID-19 related pneumonia.","volume":"29","author":"Bhurayanontachai","year":"2021","journal-title":"Clin Crit Care."},{"key":"B15","article-title":"Extracorporeal membrane oxygenation (ECMO) for COVID-19 patients.","volume":"29","author":"Tongyoo","year":"2021","journal-title":"Clin Crit Care."},{"key":"B16","year":"2022","journal-title":"Thai Clinical Practice Guidelines for COVID-19 Patients"},{"key":"B17","article-title":"Anti-inflammatory agents other than corticosteroid in SARs-CoV-2 pneumonia.","volume":"29","author":"Theerawit","year":"2021","journal-title":"Clin Crit Care."},{"key":"B18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","article-title":"An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy.","volume":"199","author":"Roca","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: the Berlin Definition.","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA."},{"key":"B21","year":"2011","journal-title":"IBM SPSS Statistics for Windows, Version 20.0."},{"key":"B22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a Review.","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19.","volume":"383","author":"Berlin","year":"2020","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 \u2013 Final Report.","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.2021.11330","article-title":"Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: a Meta-analysis.","volume":"326","author":"Sterne","year":"2021","journal-title":"JAMA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med."},{"key":"B27","year":"2022","journal-title":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines."},{"key":"B28","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S2213-2600(22)00088-1","article-title":"Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.","volume":"10","author":"Wolfe","year":"2022","journal-title":"Lancet Respir Med."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.21.0750","article-title":"Three waves of COVID-19 in a Norwegian local hospital.","volume":"141","author":"Myrstad","year":"2021","journal-title":"Tidsskr Nor Laegeforen."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e961","DOI":"10.1016\/S2214-109X(22)00114-0","article-title":"Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.","volume":"10","author":"Jassat","year":"2022","journal-title":"Lancet Glob Health."},{"key":"B31","year":"2022","journal-title":"Viralpneumonia."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1056\/NEJMoa2113017","article-title":"Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.","volume":"385","author":"El Sahly","year":"2021","journal-title":"N Engl J Med."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1088","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"BMJ."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258260","article-title":"Clinical characteristics and outcomes of hospitalized patients with SARS-CoV-2 infection in a Latin American country: results from the ECCOVID multicenter prospective study.","volume":"16","author":"Cordova","year":"2021","journal-title":"PLoS One."},{"key":"B38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial.","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: the REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1111\/bjh.16950","article-title":"Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19.","volume":"190","author":"Maquet","year":"2020","journal-title":"Br J Haematol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/09537104.2020.1754383","article-title":"Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study.","volume":"31","author":"Liu","year":"2020","journal-title":"Platelets."},{"key":"B43","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19.","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1111\/bjh.16817","article-title":"The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants.","volume":"190","author":"Jiang","year":"2020","journal-title":"Br J Haematol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41581-020-00356-5","article-title":"COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.","volume":"16","author":"Nadim","year":"2020","journal-title":"Nat Rev Nephrol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2213-2600(20)30229-0","article-title":"Management of acute kidney injury in patients with COVID-19.","volume":"8","author":"Ronco","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00277-020-04019-0","article-title":"Mechanism of thrombocytopenia in COVID-19 patients.","volume":"99","author":"Xu","year":"2020","journal-title":"Ann Hematol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1061955\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T17:00:45Z","timestamp":1672851645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1061955\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":48,"alternative-id":["10.3389\/fmed.2022.1061955"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1061955","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1061955"}}